The mOS, on the other hand, numerically trended in favor of non-DHL with mOS 21 months for DHL vs NR for others, but this did not reach statistical significance ( p = 0.6 [Fig. 1C ]).
← all excerpts
Double hit & double expressor lymphomas: a multicenter analysis of survival outcomes with CD19-directed CAR T-cell therapy.
1
0.6000
0.6000